Among these biomarkers, the lectine like oxidized low density lipoprotein receptor-1 (LOX-1) has been recently reported as playing a pivotal role for ox-LDL receptor and the related downstream signaling pathways in the onset, progression, and metastasis of cancer [2]. The gene discussed is OLR1; the disease is cancer.